TrialAntimicrobial agents and chemotherapy2015

A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis.

J Viljoen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.